Evofem Biosciences Inc. (NASDAQ: EVFM) started the day on May 17, 2021, with a price increase of 2.40% at $1.28. During the day, the stock rose to $1.28 and sunk to $1.21 before settling in for the price of $1.25 at the close. Taking a more long-term approach, EVFM posted a 52-week range of $1.12-$6.87.
Meanwhile, its Annual Earning per share during the time was 35.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.50%. This publicly-traded company’s shares outstanding now amounts to $81.84 million, simultaneously with a float of $78.84 million. The organization now has a market capitalization sitting at $128.51 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8236, while the 200-day Moving Average is $2.5482.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 147 workers. It has generated 3,034 per worker during the last fiscal year. Meanwhile, its income per employee was -968,088. The stock had 0.45 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -269.73, operating margin was -23234.08 and Pretax Margin of -31906.95.
Evofem Biosciences Inc. (EVFM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Evofem Biosciences Inc.’s current insider ownership accounts for 2.40%, in contrast to 34.80% institutional ownership. According to the most recent insider trade that took place on Mar 09, this organization’s Chief Executive Officer bought 45,249 shares at the rate of 2.28, making the entire transaction reach 103,168 in total value, affecting insider ownership by 906,137. Preceding that transaction, on Nov 17, Company’s Chief Financial Officer bought 7,760 for 2.17, making the whole transaction’s value amount to 16,839. This particular insider is now the holder of 258,168 in total.
Evofem Biosciences Inc. (EVFM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.5 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.36) by -$0.14. This company achieved a net margin of -31907.85 while generating a return on equity of -1,675.90. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
Evofem Biosciences Inc.’s EPS decrease for this current 12-month fiscal period is -6.50% and is forecasted to reach -1.05 in the upcoming year.
Evofem Biosciences Inc. (NASDAQ: EVFM) Trading Performance Indicators
Let’s observe the current performance indicators for Evofem Biosciences Inc. (EVFM). It’s Quick Ratio in the last reported quarter now stands at 0.90. The Stock has managed to achieve an average true range (ATR) of 0.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 80.32.
In the same vein, EVFM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.34, a figure that is expected to reach -0.43 in the next quarter, and analysts are predicting that it will be -1.05 at the market close of one year from today.
Technical Analysis of Evofem Biosciences Inc. (EVFM)
If we take a close look at the recent performances of Evofem Biosciences Inc. (NASDAQ: EVFM), its last 5-days Average volume was 3.96 million that shows plunge from its year to date volume of 4.46 million. During the previous 9 days, stock’s Stochastic %D was recorded 40.75% While, its Average True Range was 0.1159.
Raw Stochastic average of Evofem Biosciences Inc. (EVFM) in the period of the previous 100 days is set at 3.63%, which indicates a major fall in contrast to 38.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 46.64% that was lower than 117.38% volatility it exhibited in the past 100-days period.